Overview

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis

Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of defined green tea catechin extract and to see how well it works in preventing liver cancer in patients with cirrhosis. Higher levels of the molecule gamma-OHPdG may be found in patients with cirrhosis, which may mean a higher risk of the development of liver cancer. Defined green tea catechin extract may work better to lower levels of gamma-OHPdG and prevent the development of liver cancer.
Phase:
Phase 1
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Epigallocatechin gallate